Neumo­ra, Rayze­Bio look to each raise $200M+ in IPOs

Two biotech com­pa­nies, Neumo­ra and Rayze­Bio, hashed out their IPO plans Mon­day morn­ing, de­tail­ing hopes to raise around $227 mil­lion and $206 mil­lion, re­spec­tive­ly, in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER